The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127562261 12756226 1 I 20160623 20160630 20160916 20160916 EXP JP-GLAXOSMITHKLINE-JP2016JPN094101 GLAXOSMITHKLINE 42.66 YR F Y 0.00000 20160916 CN JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127562261 12756226 1 PS LAMICTAL LAMOTRIGINE 1 25 MG, QD 28025 MG Y N 20241 25 MG TABLET QD
127562261 12756226 2 SS LAMICTAL LAMOTRIGINE 1 Oral 50 MG, QD 28025 MG Y N 20241 50 MG TABLET QD
127562261 12756226 3 SS LAMICTAL LAMOTRIGINE 1 Oral 50 MG, BID 28025 MG Y N 20241 50 MG TABLET BID
127562261 12756226 4 SS LAMICTAL LAMOTRIGINE 1 Oral 125 MG, 1D 28025 MG Y N 20241 125 MG TABLET QD
127562261 12756226 5 SS LAMICTAL LAMOTRIGINE 1 Oral 150 MG, 1D 28025 MG Y N 20241 150 MG TABLET QD
127562261 12756226 6 SS LAMICTAL LAMOTRIGINE 1 Oral 175 MG, 1D 28025 MG Y N 20241 175 MG TABLET QD
127562261 12756226 7 SS LAMICTAL LAMOTRIGINE 1 Oral 100 MG, BID 28025 MG Y N 20241 100 MG TABLET BID
127562261 12756226 8 SS LAMICTAL LAMOTRIGINE 1 225 MG, 1D 28025 MG Y N 20241 225 MG TABLET QD
127562261 12756226 9 SS LAMICTAL LAMOTRIGINE 1 Oral UNK 28025 MG Y N 20241 TABLET
127562261 12756226 10 C CYMBALTA DULOXETINE HYDROCHLORIDE 1 20 MG, QD 0 20 MG QD
127562261 12756226 11 C QUETIAPINE. QUETIAPINE 1 25 MG, QD 0 25 MG QD
127562261 12756226 12 C REFLEX MIRTAZAPINE 1 30 MG, QD 0 30 MG QD
127562261 12756226 13 C ZOPICLONE ZOPICLONE 1 7.5 MG, QD 0 7.5 MG QD
127562261 12756226 14 C DIAZEPAM. DIAZEPAM 1 5 MG, PRN 0 15 MG
127562261 12756226 15 C LOXONIN LOXOPROFEN SODIUM 1 2 DF, BID 0 2 DF BID
127562261 12756226 16 C MIDODRINE TABLET 2 2 MG, BID 0 2 MG BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127562261 12756226 1 Bipolar disorder
127562261 12756226 14 Anxiety

Outcome of event

Event ID CASEID OUTC COD
127562261 12756226 HO
127562261 12756226 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127562261 12756226 Altered state of consciousness
127562261 12756226 Aura
127562261 12756226 Disorientation
127562261 12756226 Headache
127562261 12756226 Hypokalaemia
127562261 12756226 Irritability
127562261 12756226 Muscle rigidity
127562261 12756226 Overdose
127562261 12756226 Somnolence
127562261 12756226 Staring
127562261 12756226 Status epilepticus
127562261 12756226 Treatment noncompliance
127562261 12756226 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127562261 12756226 1 20151102 20151116 0
127562261 12756226 2 20151117 20151129 0
127562261 12756226 3 20151130 20160111 0
127562261 12756226 4 20160112 20160403 0
127562261 12756226 5 20160404 20160424 0
127562261 12756226 6 20160425 20160619 0
127562261 12756226 7 20160620 0
127562261 12756226 9 20160623 20160623 0